Home LiteratureArticle Details
PMID: 6896641 Published · ppublish English Journal Article

The incidence and the results of active treatment of acute retrolental fibroplasia.

Australian journal of ophthalmology ·Vol. 10 ·No. 2 ·1982-05-00 ·Pages 135-40

Stark DJ, Manning LM, Lenton L

Abstract

Over a four year period three hundred and thirty-nine (339) "at risk" premature neonates were examined, and sixty-five (65) cases of acute R.L.F. (19%) were detected. The overall observed incidence of acute R.L.F. in these surviving babies under 1000 gms birthweight was 47%, in those whose birthweight was 1001-1500 gms the incidence was 22%. The incidence of acute R.L.F., in those babies whose birthweight was greater than 1501-2000 gms was 4.0%. Most of the cases of acute R.L.F. that were detected occurred in those infants with a birth weight less than 1500 gms. Seventy-eight per cent (78%) of these cases of acute R.L.F. were mild and resolved spontaneously. Severe cases occurred only in those babies with a very low birthweight (less than 1100 gms). Active treatment with cryopexy or photocoagulation was undertaken in 15 eyes of 9 infants. Thirteen (13) of the fifteen (15) eyes treated resolved, and there were no blind patients in the series at the end of the study.

MeSH Terms
Acute Disease Birth Weight Cryosurgery Humans Infant Infant, Newborn Infant, Premature Light Coagulation Retinopathy of Prematurity/diagnosis,epidemiology,surgery
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Stark D J
Manning L M
Lenton L
Article Info
Journal
Australian journal of ophthalmology
Abbr.
Aust J Ophthalmol
ISSN
0310-1177
Published
1982-05-00
Pages
135-40
Language
English
Region
Australia
NLM ID
0365543
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]